Profile data is unavailable for this security.
About the company
Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. Its portfolio also includes fiber optic sensor technology in the interventional cardiology market.
- Revenue in USD (TTM)1.27bn
- Net income in USD126.57m
- Incorporated1985
- Employees3.03k
- LocationHaemonetics Corp125 Summer StreetBOSTON 02110United StatesUSA
- Phone+1 (781) 848-7100
- Websitehttps://www.haemonetics.com
More ▼
Mergers & acquisitions
| Acquired company | HAE:NYQ since announced | Transaction value |
|---|---|---|
| Advanced Cooling Therapy Inc | 21.68% | 160.00m |
| Opsens Inc | 0.26% | 245.87m |
Data delayed at least 15 minutes, as of Apr 26 2024 21:10 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tandem Diabetes Care Inc | 747.72m | -222.61m | 2.33bn | 2.40k | -- | 7.43 | -- | 3.12 | -3.44 | -3.44 | 11.51 | 4.78 | 0.7457 | 2.82 | 6.79 | 311,549.20 | -22.20 | -10.08 | -27.07 | -12.23 | 49.17 | 51.77 | -29.77 | -11.59 | 3.02 | -- | 0.4761 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| Premier Inc | 1.32bn | 167.33m | 2.49bn | 2.80k | 14.93 | 1.04 | 8.48 | 1.89 | 1.39 | 1.39 | 10.97 | 19.95 | 0.3571 | 4.57 | 3.06 | 470,033.20 | 4.42 | 10.39 | 5.67 | 13.00 | 67.13 | 62.04 | 12.37 | 22.60 | 1.32 | 516.34 | 0.2431 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| Procept Biorobotics Corp | 136.19m | -105.90m | 2.66bn | 626.00 | -- | 9.45 | -- | 19.56 | -2.24 | -2.24 | 2.88 | 5.53 | 0.3815 | 1.91 | 4.28 | 217,557.50 | -29.66 | -- | -33.47 | -- | 52.17 | -- | -77.75 | -- | 6.77 | -- | 0.1546 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| TransMedics Group Inc | 241.62m | -25.03m | 2.93bn | 584.00 | -- | 21.25 | -- | 12.13 | -0.7685 | -0.7685 | 7.43 | 4.20 | 0.4915 | 2.70 | 5.30 | 413,738.00 | -5.09 | -16.08 | -5.53 | -17.95 | 63.77 | 65.37 | -10.36 | -40.47 | 8.49 | -- | 0.7868 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| LivaNova PLC | 1.15bn | 17.55m | 2.97bn | 2.90k | 171.00 | 2.33 | 43.81 | 2.58 | 0.3222 | 0.3222 | 21.32 | 23.70 | 0.4883 | 2.76 | 5.79 | 397,774.10 | 0.7472 | -6.01 | 0.8627 | -7.42 | 66.86 | 66.99 | 1.53 | -13.56 | 2.51 | 1.10 | 0.3147 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| Enovis Corp | 1.71bn | -54.37m | 3.02bn | 6.55k | -- | 0.88 | 18.51 | 1.77 | -0.9987 | -0.6117 | 31.33 | 62.61 | 0.3888 | 1.59 | 6.11 | 260,640.80 | -1.23 | -0.3569 | -1.37 | -0.41 | 58.21 | 48.19 | -3.15 | -1.06 | 1.16 | 1.02 | 0.1199 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| Axonics Inc | 366.38m | -6.09m | 3.39bn | 797.00 | -- | 5.30 | 532.27 | 9.26 | -0.1285 | -0.1285 | 7.43 | 12.56 | 0.5313 | 1.35 | 7.18 | 459,697.60 | -0.8828 | -12.67 | -0.9601 | -13.76 | 74.94 | 70.04 | -1.66 | -29.68 | 8.98 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
| Envista Holdings Corp | 2.57bn | -100.20m | 3.44bn | 12.80k | -- | 0.8226 | 97.19 | 1.34 | -0.6022 | -0.6022 | 14.65 | 24.34 | 0.3891 | 3.99 | 6.41 | 200,507.80 | -1.52 | 1.94 | -1.79 | 2.34 | 56.52 | 57.65 | -3.90 | 5.29 | 1.90 | 5.12 | 0.2661 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| Integer Holdings Corp | 1.63bn | 98.09m | 3.72bn | 10.50k | 38.54 | 2.44 | 18.71 | 2.28 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.92 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.52 | 26.94 | 6.01 | 6.40 | 2.01 | 3.66 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Merit Medical Systems Inc | 1.26bn | 94.41m | 4.26bn | 6.95k | 45.36 | 3.53 | 23.11 | 3.39 | 1.62 | 1.62 | 21.55 | 20.78 | 0.6304 | 2.36 | 7.34 | 180,916.00 | 4.73 | 2.45 | 5.30 | 2.77 | 46.44 | 44.50 | 7.51 | 3.91 | 3.95 | 9.89 | 0.4064 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Haemonetics Corporation | 1.27bn | 126.57m | 4.45bn | 3.03k | 35.47 | 4.72 | 20.24 | 3.50 | 2.47 | 2.47 | 24.80 | 18.57 | 0.6229 | 2.11 | 6.47 | 418,649.00 | 6.21 | 4.74 | 7.05 | 5.89 | 53.48 | 49.87 | 9.97 | 7.41 | 1.76 | 26.49 | 0.48 | 0.00 | 17.67 | 5.27 | 166.05 | 9.48 | 8.06 | -- |
| Lantheus Holdings Inc | 1.30bn | 326.66m | 4.47bn | 834.00 | 14.05 | 5.48 | 11.56 | 3.45 | 4.64 | 4.64 | 18.59 | 11.91 | 0.8723 | 9.46 | 5.21 | 1,554,471.00 | 21.98 | 6.69 | 25.75 | 7.73 | 63.71 | 53.90 | 25.20 | 9.02 | 5.45 | 1,235.43 | 0.4081 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Glaukos Corp | 314.71m | -134.66m | 5.00bn | 907.00 | -- | 10.65 | -- | 15.90 | -2.78 | -2.78 | 6.50 | 9.40 | 0.324 | 1.89 | 8.29 | 346,980.20 | -13.86 | -8.73 | -14.99 | -9.35 | 75.99 | 74.77 | -42.79 | -28.69 | 4.78 | -27.68 | 0.4335 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Novanta Inc | 881.66m | 72.88m | 5.61bn | 2.90k | 77.25 | 8.31 | 46.93 | 6.36 | 2.02 | 2.02 | 24.47 | 18.80 | 0.7147 | 3.04 | 6.36 | 304,021.40 | 5.91 | 5.46 | 6.74 | 6.34 | 45.36 | 43.24 | 8.27 | 7.71 | 1.91 | 4.83 | 0.3477 | 0.00 | 2.41 | 7.49 | -1.58 | 8.21 | 4.19 | -- |
| DENTSPLY SIRONA Inc | 3.97bn | -132.00m | 6.30bn | 15.00k | -- | 1.91 | 29.86 | 1.59 | -0.6217 | -0.6217 | 18.67 | 15.89 | 0.5282 | 3.00 | 5.98 | 264,333.30 | -1.76 | -1.14 | -2.13 | -1.32 | 52.71 | 53.65 | -3.33 | -2.51 | 0.9467 | 3.63 | 0.3914 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
Data as of Apr 26 2024. Currency figures normalised to Haemonetics Corp's reporting currency: US Dollar USD
61.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 6.52m | 12.85% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 5.49m | 10.81% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 5.26m | 10.36% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2023 | 3.53m | 6.95% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 3.27m | 6.44% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.79m | 3.52% |
| Franklin Advisers, Inc.as of 31 Dec 2023 | 1.68m | 3.31% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 1.58m | 3.10% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 1.09m | 2.15% |
| Geode Capital Management LLCas of 31 Dec 2023 | 1.09m | 2.14% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
